Gapless man: machine interface in the inner ear
Gapless man: machine interface in the inner ear
批准号:
323105089
负责人:
Professor Dr. Hubert Löwenheim
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2017
资助国家:
德国
项目状态:
已结题
起止时间:
2016-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Over 5% of the world population, 360 Million people, suffer from disabling hearing loss. In severe forms, the auditory function can be restored by a neuroprostheses called a cochlear implant (CI), which functionally replaces lost inner ear sensory cells by directly stimulating the auditory nerve fibers. Despite the success of these devices, some limitations remain, including suboptimal auditory resolution and high energy consumption, which are mainly due to the anatomical gap between the implanted electrode array in the cochlea and the auditory neurons nearby. Within a recently completed, multinational EU FP7 project coordinated by the main applicant (www.nanoci.org), proof of principle for overcoming the anatomical gap by guided growth of auditory nerve fibers towards the electrode array has been obtained in vivo. In addition, in vitro experiments have shown a potential reduction of the stimulus energy by a factor of 5, if the distance of the auditory neurons from the electrode was eliminated. Within the proposed project, we intend to improve the gapless interface through optimized growth factor guidance in combination with chronic electrical stimulation and detailed morphological, biochemical and electrophysiological characterization of regrown auditory neurons in vitro and in vivo. Native and stem cell generated, donated human auditory neurons will be used in vitro for validation. The ultimate goal of the proposed project is to assess the potential of the gapless interface between auditory neurons and the cochlear implant electrodes through chronic electrical stimulation in vivo. If successful, the proposed project may lead to more energy efficient cochlear implant systems with higher auditory resolution and improved sound quality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于 CRISPR/Cas9-Man 定点编辑的红球藻细
胞厚壁构象应答机制研究
-
批准号:Q24C200031
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐冉
-
依托单位:
N-糖基转移酶 MAN1B1 通过调控 CD47 促进
膀胱癌免疫逃逸机制研究
-
批准号:Y24H160082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余燕岚
-
依托单位:
环状RNAcircMAN1A2_009编码的新蛋白MAN1A2-155aa调控T淋巴母细胞淋巴瘤/白血病复发耐药的分子机制研究
-
批准号:82370190
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:田小朋
-
依托单位:
甘露糖多效价糖簇修饰纳米纤维诱导man-PTS抗菌机制研究
-
批准号:32202136
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨维巧
-
依托单位:
海洋硝化螺旋菌门趋磁细菌的纯培养及man1-man6基因在“子弹头状”磁小体矿化中的调控作用
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘佳
-
依托单位:
IRON MAN正调控铁信号核心转录因子FIT的分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:李扬
-
依托单位:
二甲双胍通过Man-PTS系统降低粪肠球菌碱抗性的作用机制及其应用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:53万元
-
批准年份:2022
-
负责人:范伟
-
依托单位:
Man-R/SMVT 双靶向 nano-in-micro 递药系统治疗溃疡性结肠炎的作用和机制研究
-
批准号:LQ22H300009
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:张雅雯
-
依托单位:
细胞壁降解酶CEL6,MAN7,ADPG1和ADPG2在拟南芥种子脱落中的作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:何韩军
-
依托单位:
艾杜糖2-硫酸酯酶的Man6P非依赖转运机制的研究
-
批准号:81800793
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:朱莉思
-
依托单位: